Efficacy of Pre-intubation Chlorhexidine Oral Care on Health Outcomes

January 31, 2020 updated by: National Taiwan University Hospital
This single-centre, single-blind, randomised controlled study with parallel-group design was conducted in Yun Ling, Taiwan between May 2019 and August 2019. Participants were randomly allocated to an intervention (mouth care using 0.12% CHX before intubation) or control (standard care) group on a 1:1 basis. This study was approved by the institutional review board of National Taiwan University Hospital, Taiwan (IRB No.201806086RINB). Each participant completed written informed consent after explanation of this study and advised that they could withdraw anytime.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Participants were recruited at the operation room of a teaching hospital. Participants were included if they met the following criteria: 18-80 years of age, American Society of Anesthesiologists, ASA) class 1-3, scheduled for surgery under endotracheal tube intubation general anesthesia. Patients were excluded if they were diagnosed with upper or lower respiratory tract disease, including COPD, cold, had oral ulcer, scheduled to have a respiratory-related surgical procedure, had endotracheal tube intubated.

Study Type

Interventional

Enrollment (Actual)

210

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18-80 years of age, American Society of Anesthesiologists, ASA) class 1-3, scheduled for surgery under endotracheal tube intubation general anesthesia.

Exclusion Criteria:

  • Patients were excluded if they were diagnosed with upper or lower respiratory tract disease, including COPD, cold, had oral ulcer, scheduled to have a respiratory-related surgical procedure, had endotracheal tube intubated, >1 during anesthesia processes,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: intervention
receiving oral care with 20mL of 0.12% CHX by medicine cup, gargling 30 seconds.
oral care using 20mL of 0.12% CHX and gargling with 30 seconds.
NO_INTERVENTION: Control
Standardized care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bacterial Colonization (Gram stain)
Time Frame: at baseline (30 minutes before surgery started)
Bacterial Colonization
at baseline (30 minutes before surgery started)
Bacterial Colonization (Gram stain)
Time Frame: at removal of endotracheal tube (3 minutes after surgery ended and removal of endotracheal tube )
Bacterial Colonization
at removal of endotracheal tube (3 minutes after surgery ended and removal of endotracheal tube )
Bacterial Colonization (Gram stain)
Time Frame: after removal of endotracheal tube at recovery room (15 minutes after surgery ended)
Bacterial Colonization
after removal of endotracheal tube at recovery room (15 minutes after surgery ended)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breathing odor assessment using questionnaire
Time Frame: at baseline (30 minutes before surgery started)
Breathing odor assessment
at baseline (30 minutes before surgery started)
Breathing odor assessment using questionnaire
Time Frame: at insertion of endotracheal tube
Breathing odor assessment
at insertion of endotracheal tube
Breathing odor assessment using questionnaire
Time Frame: after removal of endotracheal tube and at recovery room (15 minutes after surgery ended)
Breathing odor assessment
after removal of endotracheal tube and at recovery room (15 minutes after surgery ended)
Breathing odor assessment using halitosis detector
Time Frame: at baseline (30 minutes before surgery started)
Breathing odor assessment
at baseline (30 minutes before surgery started)
Breathing odor assessment using halitosis detector
Time Frame: after removal of endotracheal tube and at recovery room (15 minutes after surgery ended)
Breathing odor assessment
after removal of endotracheal tube and at recovery room (15 minutes after surgery ended)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Wyee Lee, MSN, National Taiwan University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 1, 2019

Primary Completion (ACTUAL)

August 31, 2019

Study Completion (ACTUAL)

August 31, 2019

Study Registration Dates

First Submitted

January 16, 2020

First Submitted That Met QC Criteria

January 31, 2020

First Posted (ACTUAL)

February 5, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 5, 2020

Last Update Submitted That Met QC Criteria

January 31, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 201806086RINB

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgery

Clinical Trials on Oral care

3
Subscribe